| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,652 |
8,831 |
$1.73M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,240 |
7,847 |
$1.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,370 |
5,910 |
$927K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
8,471 |
7,944 |
$737K |
| T1015 |
Clinic visit/encounter, all-inclusive |
5,973 |
1,961 |
$251K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,321 |
1,284 |
$175K |
| 80053 |
Comprehensive metabolic panel |
14,534 |
13,521 |
$125K |
| G0378 |
Hospital observation service, per hour |
134 |
130 |
$109K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,665 |
3,587 |
$104K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
645 |
624 |
$90K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,553 |
4,283 |
$90K |
| 80050 |
General health panel |
1,776 |
1,746 |
$87K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
888 |
867 |
$77K |
| 36415 |
Collection of venous blood by venipuncture |
24,567 |
21,781 |
$76K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,804 |
15,484 |
$73K |
| 80061 |
Lipid panel |
4,699 |
4,617 |
$68K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
740 |
714 |
$65K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,496 |
1,478 |
$59K |
| 81513 |
|
494 |
487 |
$56K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,259 |
2,218 |
$52K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,146 |
4,802 |
$52K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
168 |
166 |
$43K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
903 |
842 |
$42K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
709 |
661 |
$37K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
809 |
794 |
$34K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,723 |
614 |
$32K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,571 |
2,396 |
$31K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,395 |
2,120 |
$31K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
604 |
570 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,137 |
3,934 |
$29K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
180 |
175 |
$28K |
| 84702 |
|
2,228 |
2,017 |
$27K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
207 |
199 |
$27K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,820 |
2,614 |
$26K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
262 |
165 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,082 |
3,045 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
333 |
327 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
757 |
504 |
$21K |
| 76830 |
Ultrasound, transvaginal |
440 |
431 |
$21K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
283 |
273 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
798 |
785 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
869 |
849 |
$20K |
| 97161 |
|
362 |
337 |
$20K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
451 |
441 |
$20K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
343 |
311 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
635 |
631 |
$19K |
| 84466 |
|
1,075 |
1,050 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
391 |
379 |
$17K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
247 |
237 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
767 |
755 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
491 |
478 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,122 |
1,856 |
$16K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,855 |
3,512 |
$14K |
| 87481 |
|
183 |
159 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,796 |
1,638 |
$14K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
130 |
128 |
$13K |
| 81001 |
|
6,118 |
5,783 |
$13K |
| 82607 |
|
1,017 |
995 |
$13K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
486 |
161 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
50 |
47 |
$12K |
| 95886 |
|
262 |
249 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
209 |
194 |
$12K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
73 |
73 |
$12K |
| 83735 |
|
2,251 |
1,954 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
956 |
918 |
$11K |
| 86803 |
|
545 |
537 |
$11K |
| 83880 |
|
478 |
431 |
$11K |
| 84484 |
|
1,587 |
1,453 |
$11K |
| 93971 |
|
186 |
176 |
$11K |
| 76536 |
|
210 |
206 |
$10K |
| 97162 |
|
188 |
179 |
$10K |
| 84146 |
|
379 |
373 |
$10K |
| 80081 |
|
111 |
111 |
$10K |
| 84439 |
|
1,150 |
1,119 |
$10K |
| 83540 |
|
1,137 |
1,112 |
$9K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
169 |
167 |
$9K |
| 82728 |
|
788 |
768 |
$9K |
| 71250 |
|
143 |
139 |
$9K |
| 76642 |
|
209 |
207 |
$9K |
| 76801 |
|
234 |
217 |
$9K |
| 72100 |
|
513 |
457 |
$9K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
164 |
72 |
$8K |
| 85027 |
|
1,239 |
1,102 |
$8K |
| 93976 |
|
111 |
106 |
$8K |
| 87653 |
|
189 |
185 |
$8K |
| 86618 |
|
311 |
305 |
$8K |
| J1756 |
Injection, iron sucrose, 1 mg |
154 |
65 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
382 |
364 |
$7K |
| 96376 |
|
268 |
193 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$7K |
| 93017 |
|
191 |
190 |
$7K |
| 83690 |
|
1,845 |
1,718 |
$7K |
| 73564 |
|
314 |
276 |
$6K |
| 84403 |
|
209 |
206 |
$6K |
| 83516 |
|
279 |
276 |
$6K |
| 77066 |
Tomosynthesis, mammo |
74 |
73 |
$6K |
| 82570 |
|
823 |
800 |
$6K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
676 |
640 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
176 |
168 |
$5K |
| 83970 |
|
138 |
133 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
715 |
576 |
$5K |
| 87799 |
|
60 |
58 |
$5K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
95 |
91 |
$5K |
| 94729 |
|
174 |
169 |
$5K |
| 85610 |
|
1,510 |
1,159 |
$5K |
| 82043 |
|
555 |
547 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
57 |
56 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
783 |
751 |
$5K |
| 73030 |
|
307 |
273 |
$4K |
| 82784 |
|
231 |
229 |
$4K |
| 72110 |
|
203 |
197 |
$4K |
| 73221 |
|
14 |
14 |
$4K |
| 87493 |
|
101 |
100 |
$4K |
| 84402 |
|
138 |
136 |
$4K |
| 87077 |
|
588 |
563 |
$4K |
| 73610 |
|
235 |
208 |
$4K |
| 86038 |
|
246 |
239 |
$4K |
| 87340 |
|
263 |
256 |
$4K |
| 82105 |
|
185 |
180 |
$4K |
| 87186 |
|
495 |
472 |
$4K |
| 86850 |
|
480 |
452 |
$4K |
| 76770 |
|
82 |
82 |
$4K |
| 73630 |
|
327 |
275 |
$4K |
| 82746 |
|
317 |
309 |
$4K |
| 72141 |
|
12 |
12 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
364 |
347 |
$3K |
| 95910 |
|
59 |
55 |
$3K |
| 85379 |
|
493 |
472 |
$3K |
| 73502 |
|
183 |
164 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
71 |
70 |
$3K |
| 77065 |
Tomosynthesis, mammo |
44 |
42 |
$3K |
| 70496 |
|
27 |
25 |
$3K |
| 87040 |
|
222 |
205 |
$3K |
| 95800 |
|
24 |
24 |
$3K |
| 80076 |
|
296 |
277 |
$3K |
| 82248 |
|
458 |
420 |
$3K |
| 82550 |
|
465 |
428 |
$3K |
| 84100 |
|
449 |
315 |
$3K |
| 73130 |
|
238 |
180 |
$3K |
| 84153 |
|
112 |
112 |
$3K |
| 72050 |
|
104 |
104 |
$3K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
114 |
114 |
$2K |
| 85730 |
|
524 |
500 |
$2K |
| 83605 |
|
445 |
403 |
$2K |
| 85652 |
|
782 |
700 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
52 |
49 |
$2K |
| 72040 |
|
142 |
121 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
54 |
52 |
$2K |
| 94726 |
|
77 |
77 |
$2K |
| 86140 |
|
696 |
602 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
63 |
60 |
$2K |
| 86765 |
|
150 |
147 |
$2K |
| 70498 |
|
15 |
13 |
$2K |
| 74018 |
|
168 |
154 |
$2K |
| 82565 |
|
342 |
311 |
$2K |
| 94060 |
|
176 |
171 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
959 |
770 |
$2K |
| 87512 |
|
65 |
63 |
$2K |
| 82947 |
|
806 |
647 |
$2K |
| 73562 |
|
126 |
106 |
$2K |
| 86592 |
|
407 |
399 |
$2K |
| 83001 |
|
87 |
87 |
$2K |
| 83721 |
|
136 |
134 |
$2K |
| 77062 |
|
65 |
65 |
$1K |
| 76981 |
|
24 |
24 |
$1K |
| 82950 |
|
190 |
188 |
$1K |
| 87209 |
|
59 |
59 |
$1K |
| 86901 |
|
379 |
339 |
$1K |
| 86900 |
|
379 |
339 |
$1K |
| 84550 |
|
181 |
170 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
27 |
24 |
$1K |
| 82977 |
|
108 |
101 |
$1K |
| 84156 |
|
244 |
222 |
$1K |
| 87427 |
|
70 |
70 |
$945.46 |
| 96367 |
|
66 |
37 |
$910.92 |
| 97014 |
|
43 |
12 |
$881.94 |
| 83615 |
|
113 |
105 |
$840.24 |
| 82150 |
|
153 |
150 |
$823.03 |
| 93970 |
|
13 |
13 |
$816.53 |
| 95911 |
|
14 |
12 |
$811.22 |
| 84704 |
|
48 |
48 |
$809.37 |
| 84163 |
|
46 |
46 |
$772.87 |
| 86376 |
|
86 |
86 |
$751.23 |
| 80074 |
|
12 |
12 |
$726.74 |
| 83002 |
|
38 |
37 |
$722.63 |
| 87081 |
|
133 |
131 |
$712.92 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
440 |
315 |
$694.86 |
| 80069 |
|
76 |
65 |
$693.59 |
| 84481 |
|
27 |
27 |
$683.53 |
| 90715 |
|
44 |
38 |
$663.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,289 |
1,891 |
$617.34 |
| 83993 |
|
27 |
27 |
$608.98 |
| 86431 |
|
76 |
73 |
$605.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,188 |
3,638 |
$603.47 |
| 87328 |
|
39 |
39 |
$576.40 |
| 83921 |
|
30 |
30 |
$556.30 |
| 87045 |
|
70 |
70 |
$535.74 |
| 97164 |
|
15 |
15 |
$528.38 |
| 87329 |
|
39 |
39 |
$515.30 |
| 87177 |
|
59 |
59 |
$484.01 |
| 81025 |
|
147 |
143 |
$459.60 |
| 83655 |
|
39 |
37 |
$458.50 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,498 |
3,678 |
$447.37 |
| 86706 |
|
36 |
36 |
$443.67 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
876 |
725 |
$428.93 |
| 82247 |
|
65 |
43 |
$395.90 |
| 81003 |
|
115 |
114 |
$380.85 |
| 87046 |
|
70 |
70 |
$362.71 |
| 84520 |
|
97 |
92 |
$339.78 |
| 94760 |
|
18 |
17 |
$324.51 |
| 82627 |
|
14 |
14 |
$322.56 |
| J2704 |
Injection, propofol, 10 mg |
964 |
777 |
$313.63 |
| 83525 |
|
29 |
28 |
$297.55 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,251 |
1,044 |
$293.86 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
101 |
70 |
$278.64 |
| 87015 |
|
39 |
39 |
$276.54 |
| 94727 |
|
14 |
13 |
$233.66 |
| 73590 |
|
12 |
12 |
$219.98 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
335 |
304 |
$216.97 |
| 84460 |
|
27 |
27 |
$184.32 |
| 86039 |
|
12 |
12 |
$174.75 |
| 84450 |
|
27 |
27 |
$173.60 |
| 80055 |
|
13 |
13 |
$168.60 |
| 83520 |
|
12 |
12 |
$159.56 |
| 82533 |
|
13 |
12 |
$156.41 |
| 72072 |
|
13 |
13 |
$155.98 |
| 82951 |
|
12 |
12 |
$150.67 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
418 |
308 |
$140.97 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,086 |
854 |
$138.07 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
815 |
735 |
$124.71 |
| 87205 |
|
29 |
29 |
$112.92 |
| 86308 |
|
15 |
15 |
$104.77 |
| 88304 |
|
27 |
27 |
$101.52 |
| 87070 |
|
12 |
12 |
$89.73 |
| 82040 |
|
27 |
26 |
$82.40 |
| 76882 |
|
14 |
13 |
$73.99 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
170 |
153 |
$67.11 |
| 80051 |
|
13 |
12 |
$66.51 |
| 82310 |
|
13 |
13 |
$61.00 |
| J2060 |
Injection, lorazepam, 2 mg |
180 |
143 |
$48.39 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
105 |
65 |
$45.56 |
| 87147 |
|
14 |
14 |
$43.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
451 |
336 |
$37.14 |
| A9270 |
Non-covered item or service |
75 |
56 |
$35.52 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
148 |
122 |
$13.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
77 |
65 |
$11.38 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
30 |
27 |
$5.91 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
20 |
17 |
$2.70 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
305 |
278 |
$0.02 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
12 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
309 |
266 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
18 |
14 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
14 |
13 |
$0.00 |